Literature DB >> 9201689

Quantitative assessment of tuftsin receptor expression and second messenger during in vitro differentiation of peripheral blood derived monocytes of leprosy patients.

S Khare1, L K Bhutani, D N Rao.   

Abstract

Tuftsin, a tetrapeptide (Thr-Lys-Pro-Arg) is known to potentiate the immunogenic activity of antigen-fed macrophages. The present study describes the mechanism of action of tuftsin in leprosy patients throughout the spectrum of the disease in vitro as a function of culture age in terms of (A) involvement of second messengers cAMP, cGMP and [Ca2+]i and (B) number of tuftsin binding sites/and their relative affinities on the monocytes/macrophages. There is apparently no direct involvement of either cAMP or cGMP while comparing the stimulated and unstimulated cultures during in vitro differentiation of monocytes (days 1, 3 and 7) or with the spectrum of the disease. Inhibition of superoxide anion release either by verapamil or with Quin 2 clearly demonstrated the involvement of [Ca2+]i as a second messenger during activation of monocytes/macrophages with tuftsin. Scatchard analysis of radiolabelled tuftsin binding data showed only one type of tuftsin receptor (low affinity) on BL/ LL monocytes/macrophages and normal and BT/TT cultures showed a gradual change in receptor number and affinities (low to high) with the maturation of monocytes to macrophages in contrast to BL/LL groups which displayed significantly less number of receptors. This study elicits a model which depicts that the biological responses/metabolic functions of early monocytes of normal and BT/TT gradually increase with the age of the culture till day 3 and tapers off thereafter in the older (day 7) cultures, whereas the monocytes/macrophages of BL/LL group are metabolically active only on day 1. The present study thereby implies that the clearance of leprosy bacilli from lepromatous leprosy lesions as a consequence of local or systemic immunotherapy (in the present study, the macrophage modulation by tuftsin) depends on the influx of new competent macrophages, rather than the local activation of resident lepromatous macrophages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201689     DOI: 10.1023/a:1006861509742

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  15 in total

1.  Quantitative assessment of Fc receptor expression and function during in vitro differentiation of human monocytes to macrophages.

Authors:  T W Jungi; S Hafner
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

Review 2.  Inositol trisphosphate and diacylglycerol: two interacting second messengers.

Authors:  M J Berridge
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  "Tuftsin": a natural phagocytosis stimulating peptide.

Authors:  V A Najjar; K Nishioka
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

4.  Effect of tuftsin stimulation on the microbicidal activity exerted by blood monocyte-macrophages of leprosy patients.

Authors:  R R Iyer; H K Prasad; L K Bhutani; D N Rao
Journal:  Int J Immunopharmacol       Date:  1990

5.  Modulation of human lepromatous monocyte-macrophage functions in vitro by tuftsin.

Authors:  R R Iyer; H K Prasad; L K Bhutani; D N Rao
Journal:  Int J Immunopharmacol       Date:  1990

6.  Modulation of peripheral blood derived monocytes/macrophages from leprosy patients using 'tuftsin' for production of reactive oxygen intermediates.

Authors:  S Khare; L K Bhutani; D N Rao
Journal:  Lepr Rev       Date:  1993-09       Impact factor: 0.537

7.  Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

8.  The depression of phagocytosis by exogenous cyclic nucleotides, prostaglandins, and theophylline.

Authors:  J P Cox; M L Karnovsky
Journal:  J Cell Biol       Date:  1973-11       Impact factor: 10.539

9.  Defective production of monocyte-activating cytokines in lepromatous leprosy.

Authors:  M A Horwitz; W R Levis; Z A Cohn
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

10.  Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.

Authors:  N Nogueira; G Kaplan; E Levy; E N Sarno; P Kushner; A Granelli-Piperno; L Vieira; V Colomer Gould; W Levis; R Steinman
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  1 in total

1.  Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.

Authors:  Anirudh Gairola; Aaron Benjamin; Joshua D Weatherston; Jeffrey D Cirillo; Hung-Jen Wu
Journal:  Adv Ther (Weinh)       Date:  2022-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.